Cell-cell communications shape tumor microenvironment and predict clinical outcomes in clear cell renal carcinoma

被引:18
作者
Chen, Liu-xun [1 ]
Zeng, Shen-jie [2 ]
Liu, Xv-dong [2 ]
Tang, Hai-bin [2 ]
Wang, Jia-wu [1 ]
Jiang, Qing [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Urol, 1 Yixueyuan Rd, Chongqing, Peoples R China
[2] Chongqing Med Univ, Clin Inst 1, Chongqing, Peoples R China
关键词
Cell-cell communications; Tumor microenvironment; Clear cell renal carcinoma; Prognosis; Immunotherapy; EXPRESSION;
D O I
10.1186/s12967-022-03858-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundCell-cell communications of various cell populations within tumor microenvironment play an essential role in primary tumor growth, metastasis evolution, and immune escape. Nevertheless, comprehensive investigation of cell-cell communications in the ccRCC (Clear cell renal carcinoma) microenvironment and how this interplay affects prognosis still remains limited.MethodsIntercellular communications were characterized by single-cell data. Firstly, we employed "CellChat" package to characterize intercellular communications across all types of cells in microenvironment in VHL mutated and non-mutated samples from 8 patients, respectively. And pseudotime trajectory analyses were performed with monocle analyses. Finally clinical prognosis and immunotherapy efficacy with different landscapes of intercellular interplay are evaluated by TCGA-KIRC and immunotherapy cohort.ResultsFirstly, the VHL phenotype may be related to the intercellular communication landscape. And trajectory analysis reveals the potential relationship of cell-cell communication molecules with T cells and Myeloid cells differentiation. Furthermore, those molecules also correlate with the infiltration of T cells and Myeloid cells. A tumor cluster with highly expressed ligands was defined by quantitative analysis and transcription factor enrichment analysis, which was identified to be pivotal for intercellular communications in tumor microenvironment. Finally, bulk data indicates bulk that different clusters with different intercellular communications have significant predictive value for prognosis and distinguished immunotherapy efficiency.ConclusionsThe intercellular communication landscapes of VHL wild and VHL mutant ccRCC vary. Intercellular communications within the tumor microenvironment also influence T cell and myeloid cell development and infiltration, as well as predict clinical prognosis and immunotherapy efficacy in ccRCC.
引用
收藏
页数:16
相关论文
共 25 条
[1]  
Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/nmeth.4463, 10.1038/NMETH.4463]
[2]   Deciphering cell-cell interactions and communication from gene expression [J].
Armingol, Erick ;
Officer, Adam ;
Harismendy, Olivier ;
Lewis, Nathan E. .
NATURE REVIEWS GENETICS, 2021, 22 (02) :71-88
[3]   Treatment of renal cell carcinoma: Current status and future directions [J].
Barata, Pedro C. ;
Rini, Brian I. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (06) :507-524
[4]   Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma [J].
Bi, Kevin ;
He, Meng Xiao ;
Bakouny, Ziad ;
Kanodia, Abhay ;
Napolitano, Sara ;
Wu, Jingyi ;
Grimaldi, Grace ;
Braun, David A. ;
Cuoco, Michael S. ;
Mayorga, Angie ;
DelloStritto, Laura ;
Bouchard, Gabrielle ;
Steinharter, John ;
Tewari, Alok K. ;
Vokes, Natalie, I ;
Shannon, Erin ;
Sun, Maxine ;
Park, Jihye ;
Chang, Steven L. ;
McGregor, Bradley A. ;
Haq, Rizwan ;
Denize, Thomas ;
Signoretti, Sabina ;
Guerriero, Jennifer L. ;
Vigneau, Sebastien ;
Rozenblatt-Rosen, Orit ;
Rotem, Asaf ;
Regev, Aviv ;
Choueiri, Toni K. ;
Van Allen, Eliezer M. .
CANCER CELL, 2021, 39 (05) :649-+
[5]   Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma [J].
Braun, David A. ;
Hou, Yue ;
Bakouny, Ziad ;
Ficial, Miriam ;
Sant' Angelo, Miriam ;
Forman, Juliet ;
Ross-Macdonald, Petra ;
Berger, Ashton C. ;
Jegede, Opeyemi A. ;
Elagina, Liudmilla ;
Steinharter, John ;
Sun, Maxine ;
Wind-Rotolo, Megan ;
Pignon, Jean-Christophe ;
Cherniack, Andrew D. ;
Lichtenstein, Lee ;
Neuberg, Donna ;
Catalano, Paul ;
Freeman, Gordon J. ;
Sharpe, Arlene H. ;
McDermott, David F. ;
Van Allen, Eliezer M. ;
Signoretti, Sabina ;
Wu, Catherine J. ;
Shukla, Sachet A. ;
Choueiri, Toni K. .
NATURE MEDICINE, 2020, 26 (06) :909-+
[6]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[7]   Targeting renal cell carcinoma with a HIF-2 antagonist [J].
Chen, Wenfang ;
Hill, Haley ;
Christie, Alana ;
Kim, Min Soo ;
Holloman, Eboni ;
Pavia-Jimenez, Andrea ;
Homayoun, Farrah ;
Ma, Yuanqing ;
Patel, Nirav ;
Yell, Paul ;
Hao, Guiyang ;
Yousuf, Qurratulain ;
Joyce, Allison ;
Pedrosa, Ivan ;
Geiger, Heather ;
Zhang, He ;
Chang, Jenny ;
Gardner, Kevin H. ;
Bruick, Richard K. ;
Reeves, Catherine ;
Hwang, Tae Hyun ;
Courtney, Kevin ;
Frenkel, Eugene ;
Sun, Xiankai ;
Zojwalla, Naseem ;
Wong, Tai ;
Rizzi, James P. ;
Wallace, Eli M. ;
Josey, John A. ;
Xie, Yang ;
Xie, Xian-Jin ;
Kapur, Payal ;
McKay, Renee M. ;
Brugarolas, James .
NATURE, 2016, 539 (7627) :112-+
[8]   Heme catabolism by tumor-associated macrophages controls metastasis formation [J].
Consonni, Francesca Maria ;
Bleve, Augusto ;
Totaro, Maria Grazia ;
Storto, Mariangela ;
Kunderfranco, Paolo ;
Termanini, Alberto ;
Pasqualini, Fabio ;
Ali, Chiara ;
Pandolfo, Chiara ;
Sgambelluri, Francesco ;
Grazia, Giulia ;
Santinami, Mario ;
Maurichi, Andrea ;
Milione, Massimo ;
Erreni, Marco ;
Doni, Andrea ;
Fabbri, Marco ;
Gribaldo, Laura ;
Rulli, Eliana ;
Soares, Miguel Parreira ;
Torri, Valter ;
Mortarini, Roberta ;
Anichini, Andrea ;
Sica, Antonio .
NATURE IMMUNOLOGY, 2021, 22 (05) :595-+
[9]   The Immunobiology of Kidney Cancer [J].
Drake, Charles G. ;
Stein, Mark N. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (36) :3547-+
[10]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674